Détention brevets de la classe A61K 31/56

Brevets de cette classe: 2922

Historique des publications depuis 10 ans

213
212
194
184
190
190
126
111
114
77
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Propriétaires principaux

Proprétaire
Total
Cette classe
The Regents of the University of California
20153
56
Sage Therapeutics, Inc.
370
29
The Johns Hopkins University
5730
28
Mexichem Fluor, Sociedad Anonima de Capital Variable
204
22
Brigham Young University
598
21
InterCept Pharmaceuticals, Inc.
203
20
Ellodi Pharmaceuticals, L.P., General Partner, Ellodi Development I Genpar, LLC, a Delaware limited liability company
28
20
Lipocine Inc.
114
19
Reata Pharmaceuticals, Inc.
117
19
Emory University
1643
18
Corcept Therapeutics, Inc.
350
17
Laboratoire Hra-pharma
151
16
Arven Ilac Sanayi Ve Ticaret A.S.
96
15
Phoenix Biotechnology, Inc.
49
15
Enanta Pharmaceuticals, Inc.
432
14
Alcon, Inc.
5495
13
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
836
13
Board of Regents, The University of Texas System
5891
12
Royalty Security, LLC
21
12
California Institute of Technology
3985
11
Autres propriétaires 2532